COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS Application EP-4269594-A3 European Patent Office 20 Dec 2023
HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND PEMBROLIZUMAB Application WO-2023122573-A1 World Intellectual Property Organisation (WIPO) 29 Jun 2023
HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND PEMBROLIZUMAB Application WO-2022256534-A1 World Intellectual Property Organisation (WIPO) 08 Dec 2022
HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB Application WO-2022256538-A1 World Intellectual Property Organisation (WIPO) 08 Dec 2022
METHODS AND KITS TO MONITOR SQUAMOUS CELL CARCINOMA Application EP-3992630-A1 European Patent Office 04 May 2022
IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES Application WO-2021263026-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2021
EXTRACELLULAR VESICLE PROTEINS AND THEIR USE FOR CANCER DIAGNOSIS, PREDICTING RESPONSE TO… Application EP-3707272-A4 European Patent Office 24 Nov 2021
COMBINATION FOR TREATING CANCER Application WO-2020095183-A1 World Intellectual Property Organisation (WIPO) 14 May 2020
COMBINATIONS FOR TREATING CANCER Application WO-2020095184-A1 World Intellectual Property Organisation (WIPO) 14 May 2020
COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND… Application WO-2019226329-A1 World Intellectual Property Organisation (WIPO) 28 Nov 2019
COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4- BENZODIAZEPINONE COMPOUNDS AND… Application WO-2019217250-A1 World Intellectual Property Organisation (WIPO) 14 Nov 2019
TREATMENT OF CNS LYMPHOMA AND SYSTEMIC LYMPHOMA WITH INTRACEREBROVENTRICULARLY… Application WO-2019094498-A1 World Intellectual Property Organisation (WIPO) 16 May 2019
COMBINATION OF A CELL THERAPY AND A GAMMA SECRETASE INHIBITOR Application WO-2019090364-A1 World Intellectual Property Organisation (WIPO) 09 May 2019
COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS Application WO-2018151836-A1 World Intellectual Property Organisation (WIPO) 23 Aug 2018